And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.

FULC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $59,071.84

Fulcrum Therapeutics Insider Trading History Chart

Fulcrum Therapeutics Share Price & Price History

^$3.26

▲ +0.05 (1.56%)

As of 11/4/2024 01:00 AM ET

Days: 30 | 90 | 365

Top "Sleeping Giant" Crypto In The Market Now

From Crypto 101 Media | Ad

Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future.

Click here to discover our #1 crypto pick before it's too late

Fulcrum Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/7/2024	Greg Tourangeau	Insider	Sell	236	$7.76	$1,831.36	11,571
3/8/2024	Greg Tourangeau	VP	Sell	4,884	$11.72	$57,240.48	11,807
5/10/2023	Greg Tourangeau	Insider	Sell	210	$3.31	$695.10	15,992
1/20/2023	Ra Capital Management, L.P.	Major Shareholder	Buy	1,923,076	$13.00	$24,999,988.00	11,609,704
1/13/2023	Robert J. Gould	CEO	Sell	6,766	$15.00	$101,490.00	499,864
1/4/2023	Ra Capital Management, L.P.	Major Shareholder	Buy	180,703	$7.28	$1,315,517.84	9,686,628
12/27/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	4,089	$5.99	$24,493.11	9,505,925
12/19/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	98,787	$5.90	$582,843.30	9,501,836
12/16/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	1,341,420	$5.42	$7,270,496.40	9,403,049
12/14/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	824,600	$5.46	$4,502,316.00	7,824,600
6/6/2022	Robert J. Gould	Director	Sell	24,382	$8.10	$197,494.20	506,630
6/3/2022	Robert J. Gould	Director	Sell	25,551	$7.95	$203,130.45	506,630
4/7/2022	Robert J. Gould	Director	Sell	5,631	$24.02	$135,256.62	506,630
4/4/2022	Robert J. Gould	Director	Sell	7,235	$24.02	$173,784.70	506,630
4/1/2022	Robert J. Gould	Director	Sell	34,464	$24.03	$828,169.92	506,630

The Final Frontier

From Porter & Company | Ad

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Fulcrum Therapeutics (NASDAQ:FULC)

89.83% of Fulcrum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fulcrum Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/25/2024	China Universal Asset Management Co. Ltd.	12,002	$43K	0.0%	+64.4%	0.019%
10/23/2024	Assenagon Asset Management S.A.	340,495	$1.22M	0.0%	-31.6%	0.548%
10/3/2024	SG Americas Securities LLC	33,019	$0.12M	0.0%	+26.5%	0.053%
8/16/2024	Algert Global LLC	41,303	$0.26M	0.0%	+202.1%	0.066%
8/15/2024	Susquehanna Portfolio Strategies LLC	81,217	$0.50M	0.0%	-51.9%	0.131%
8/15/2024	The Manufacturers Life Insurance Company	24,480	$0.15M	0.0%	N/A	0.039%
8/15/2024	Caxton Associates LP	18,875	$0.12M	0.0%	N/A	0.030%
8/14/2024	Marshall Wace LLP	333,161	$2.07M	0.0%	+47.7%	0.536%
8/14/2024	Profund Advisors LLC	10,921	$68K	0.0%	N/A	0.018%
8/13/2024	Simplify Asset Management Inc.	674,832	$4.18M	0.3%	-0.2%	1.086%
8/12/2024	Marathon Trading Investment Management LLC	10,800	$67K	0.0%	-76.0%	0.017%
8/9/2024	Renaissance Technologies LLC	13,257	$82K	0.0%	N/A	0.021%
8/9/2024	Dimensional Fund Advisors LP	1,480,926	$9.18M	0.0%	+13.5%	2.383%
8/8/2024	American Century Companies Inc.	104,371	$0.65M	0.0%	+13.2%	0.168%
8/6/2024	Quest Partners LLC	26,164	$0.16M	0.0%	N/A	0.042%
8/6/2024	Los Angeles Capital Management LLC	21,038	$0.13M	0.0%	N/A	0.034%
8/3/2024	National Bank of Canada FI	4,460	$28K	0.0%	+869.6%	0.007%
8/1/2024	Rhumbline Advisers	91,432	$0.57M	0.0%	+5,417.9%	0.147%
7/26/2024	Bank of New York Mellon Corp	186,727	$1.16M	0.0%	N/A	0.300%
7/18/2024	Assenagon Asset Management S.A.	497,456	$3.08M	0.0%	N/A	0.800%
7/12/2024	SG Americas Securities LLC	26,093	$0.16M	0.0%	+113.8%	0.042%
5/16/2024	Jane Street Group LLC	535,062	$5.05M	0.0%	+54.3%	0.861%
5/16/2024	Jacobs Levy Equity Management Inc.	20,472	$0.19M	0.0%	-83.2%	0.033%
5/14/2024	StemPoint Capital LP	407,108	$3.84M	1.0%	+8.1%	0.655%
5/10/2024	Vanguard Group Inc.	2,538,665	$23.97M	0.0%	+0.7%	4.084%
5/7/2024	SG Americas Securities LLC	12,206	$0.12M	0.0%	N/A	0.020%
5/7/2024	Marquette Asset Management LLC	6,039	$57K	0.0%	-78.3%	0.010%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	32,591	$0.31M	0.0%	N/A	0.052%
4/30/2024	Commonwealth Equity Services LLC	83,428	$0.79M	0.0%	-13.5%	0.134%
4/29/2024	Principal Financial Group Inc.	16,233	$0.15M	0.0%	-9.8%	0.026%
4/29/2024	China Universal Asset Management Co. Ltd.	11,916	$0.11M	0.0%	+66.7%	0.019%
4/19/2024	Denali Advisors LLC	27,100	$0.26M	0.1%	-53.1%	0.044%
4/4/2024	Mass General Brigham Inc	205,356	$1.94M	3.4%	N/A	0.332%
2/15/2024	Opaleye Management Inc.	130,000	$0.88M	0.2%	N/A	0.210%
2/14/2024	ADAR1 Capital Management LLC	637,405	$4.30M	1.5%	N/A	1.031%
2/14/2024	Vestal Point Capital LP	1,025,000	$6.92M	0.7%	N/A	1.658%
2/14/2024	RTW Investments LP	5,469,956	$36.92M	0.6%	-6.0%	8.848%
2/13/2024	Tower Research Capital LLC TRC	3,658	$25K	0.0%	-30.3%	0.006%
2/13/2024	Affinity Asset Advisors LLC	125,000	$0.84M	0.2%	N/A	0.202%
2/12/2024	Capstone Investment Advisors LLC	10,000	$68K	0.0%	N/A	0.016%
1/31/2024	abrdn plc	256,888	$1.73M	0.0%	N/A	0.416%
1/24/2024	China Universal Asset Management Co. Ltd.	7,150	$48K	0.0%	+348.6%	0.012%
1/19/2024	Denali Advisors LLC	57,800	$0.39M	0.1%	-18.1%	0.093%
12/7/2023	Hudson Bay Capital Management LP	196,488	$0.87M	0.0%	N/A	0.318%
12/6/2023	Citigroup Inc.	89,189	$0.40M	0.0%	+1,028.5%	0.144%
11/15/2023	RTW Investments LP	5,818,804	$25.84M	0.5%	-4.0%	9.412%
11/15/2023	Adage Capital Partners GP L.L.C.	2,406,422	$10.69M	0.0%	+4.3%	3.893%
11/14/2023	Brown Wealth Management LLC	25,000	$0.11M	0.1%	N/A	0.040%
11/13/2023	Algert Global LLC	31,010	$0.14M	0.0%	N/A	0.050%
11/13/2023	ClariVest Asset Management LLC	104,400	$0.46M	0.0%	N/A	0.169%
11/13/2023	FMR LLC	5,975,416	$26.53M	0.0%	+7.6%	9.666%
11/13/2023	DekaBank Deutsche Girozentrale	60,000	$0.27M	0.0%	N/A	0.097%
11/9/2023	Cowen AND Company LLC	4,308,359	$19.13M	1.3%	+38.2%	6.969%
11/9/2023	Citigroup Inc.	89,189	$0.40M	0.0%	+1,028.5%	0.144%
11/8/2023	Vivo Capital LLC	520,000	$2.31M	0.3%	-5.5%	0.841%
11/8/2023	Landscape Capital Management L.L.C.	28,252	$0.13M	0.0%	N/A	0.046%
11/7/2023	Jump Financial LLC	91,790	$0.41M	0.0%	N/A	0.148%
10/20/2023	Denali Advisors LLC	70,600	$0.31M	0.1%	N/A	0.114%
8/15/2023	Suvretta Capital Management LLC	5,718,881	$18.87M	1.0%	+10.5%	9.251%
8/14/2023	Prelude Capital Management LLC	11,171	$37K	0.0%	N/A	0.018%
8/14/2023	Graham Capital Management L.P.	31,948	$0.11M	0.0%	-78.3%	0.052%
8/11/2023	MYDA Advisors LLC	50,000	$0.17M	0.0%	N/A	0.081%
8/11/2023	Harvard Management Co. Inc.	341,972	$1.13M	0.1%	-16.7%	0.553%
8/10/2023	Tekla Capital Management LLC	256,888	$0.85M	0.0%	+338.8%	0.416%
8/7/2023	Cowen AND Company LLC	3,116,996	$10.29M	0.9%	+43.2%	5.042%
8/7/2023	Mirabella Financial Services LLP	32,760	$0.11M	0.0%	N/A	0.053%
7/28/2023	Marquette Asset Management LLC	27,867	$92K	0.0%	N/A	0.045%
5/15/2023	Suvretta Capital Management LLC	5,177,710	$14.76M	0.6%	+21.1%	8.384%
5/15/2023	RTW Investments LP	5,511,839	$15.71M	0.3%	+10.4%	8.925%
5/11/2023	Cornercap Investment Counsel Inc.	44,078	$0.13M	0.0%	+26.3%	0.071%
5/11/2023	Alphabet Inc.	14,262	$41K	0.0%	-94.4%	0.023%
5/10/2023	Simplify Asset Management Inc.	639,118	$1.82M	0.3%	N/A	1.035%
5/9/2023	Cowen AND Company LLC	2,176,045	$6.20M	0.7%	+59.9%	3.523%
5/9/2023	Y Intercept Hong Kong Ltd	29,663	$85K	0.0%	N/A	0.048%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	10,449	$30K	0.0%	+293.6%	0.017%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	32,274	$92K	0.0%	+137.8%	0.052%
5/1/2023	Virtu Financial LLC	31,104	$89K	0.0%	N/A	0.050%
4/28/2023	SG Americas Securities LLC	24,951	$71K	0.0%	+55.6%	0.040%
2/15/2023	Nantahala Capital Management LLC	500,000	$3.64M	0.2%	N/A	0.961%
2/14/2023	RA Capital Management L.P.	9,505,925	$69.20M	1.4%	+35.8%	18.263%
2/14/2023	VR Adviser LLC	447,326	$3.26M	0.5%	-62.7%	0.859%
2/14/2023	Alpine Global Management LLC	16,073	$0.12M	0.0%	N/A	0.031%
2/13/2023	Bessemer Group Inc.	286,988	$2.09M	0.0%	+0.4%	0.551%
2/13/2023	Cornercap Investment Counsel Inc.	34,886	$0.25M	0.0%	N/A	0.067%
2/10/2023	Tekla Capital Management LLC	58,537	$0.43M	0.0%	N/A	0.112%
2/9/2023	Landscape Capital Management L.L.C.	11,114	$81K	0.0%	N/A	0.021%
2/9/2023	Cowen AND Company LLC	1,361,169	$9.91M	1.0%	-42.0%	2.615%
2/2/2023	SG Americas Securities LLC	16,033	$0.12M	0.0%	+35.5%	0.031%
11/16/2022	Alphabet Inc.	255,452	$2.07M	0.1%	N/A	0.491%
11/16/2022	Sandia Investment Management LP	5,000	$40K	0.0%	N/A	0.010%
11/15/2022	Parkman Healthcare Partners LLC	235,385	$1.90M	0.5%	-10.4%	0.452%
11/14/2022	RTW Investments LP	3,985,910	$32.25M	0.7%	+0.6%	7.658%
11/14/2022	Point72 Asset Management L.P.	1,494,003	$12.09M	0.0%	-24.9%	2.870%
11/14/2022	RA Capital Management L.P.	7,000,000	$56.63M	1.2%	N/A	13.448%
11/14/2022	VR Adviser LLC	1,200,000	$9.71M	1.4%	N/A	2.305%
11/14/2022	MetLife Investment Management LLC	18,890	$0.15M	0.0%	N/A	0.036%
11/8/2022	Sofinnova Investments Inc.	797,262	$6.45M	0.4%	N/A	1.944%
11/8/2022	International Biotechnology Trust PLC	193,741	$1.56M	0.5%	+20,315.3%	0.472%
11/7/2022	Arizona State Retirement System	10,280	$83K	0.0%	N/A	0.025%
11/1/2022	Monashee Investment Management LLC	200,000	$1.62M	0.6%	N/A	0.488%

Data available starting January 2016

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy is under phase III clinical trial; and pociredir, a fetal hemoglobin inducer for the treatment of sickle cell disease and beta-thalassemia is under phase I clinical trial. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has collaboration and license agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and MyoKardia, Inc. to discover and develop therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $3.26

$3.13

$3.38

50 Day Range

MA: $4.68

$3.16

$8.87

52 Week Range

Now: $3.26

$2.87

$13.70

Volume

843,613 shs

Average Volume

586,241 shs

Market Capitalization

$203.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.24

Who are the company insiders with the largest holdings of Fulcrum Therapeutics?: Fulcrum Therapeutics' top insider investors include:
Ra Capital Management, LP (Major Shareholder)
Robert J Gould (CEO)
Greg Tourangeau (Insider)
Greg Tourangeau (VP)
Learn More about top insider investors at Fulcrum Therapeutics.
Who are the major institutional investors of Fulcrum Therapeutics?: Fulcrum Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.55%
SG Americas Securities LLC — 0.05%
China Universal Asset Management Co. Ltd. — 0.02%
Belvedere Trading LLC — 0.00%
Learn More about top institutional investors of Fulcrum Therapeutics stock.
Which major investors are selling Fulcrum Therapeutics stock?: Within the previous quarter, FULC stock was sold by these institutional investors:
Assenagon Asset Management S.A.
In the previous year, company insiders that have sold Fulcrum Therapeutics company stock include:
Ra Capital Management, LP (Major Shareholder)
Robert J Gould (CEO)
Learn More investors selling Fulcrum Therapeutics stock.
Which major investors are buying Fulcrum Therapeutics stock?: In the previous quarter, FULC stock was acquired by institutional investors including:
SG Americas Securities LLC
China Universal Asset Management Co. Ltd.
Belvedere Trading LLC